This study involved four major activities in estimating the current size of the pharmaceutical excipients market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size (pharmaceutical excipients market size). After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive technical, market-oriented, and commercial study of the pharmaceutical excipients market. The secondary sources used for this study include the European Federation of Pharmaceutical Industries and Associations (EFPIA), Pharmaceutical Research and Manufacturers of America (PhRMA), Parenteral Drug Association (PDA), International Pharmaceutical Excipients Council (IPEC), International Journal of Production Research (IJPR), Generics and Biosimilars Initiative (GaBI), PharmaTimes, World Journal of Pharmaceutical Sciences, International Federation of Pharmaceutical Manufacturers & Association (IFPMA), Annual Reports, SEC Filings, Investor Presentations, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives. Secondary data was collected and analyzed to arrive at the overall size of the global pharmaceutical excipients market, which was validated through primary research.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
Note: Tiers are defined based on a company’s total revenue. As of 2022, Tier 1 = >USD 1 Bn, Tier 2 = USD 500 Mn to USD 1 Bn, and Tier 3 <USD 500 Mn.
To know about the assumptions considered for the study, download the pdf brochure
Pharmaceutical Excipients Market Size Estimation
The global size of the pharmaceutical excipients market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size (pharmaceutical excipients market size) includes the following:
-
The major players in the industry and market have been identified through extensive primary and secondary research.
-
The revenues generated from the pharmaceutical excipients business of players operating in the market have been determined through secondary research and primary analysis.
-
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Pharmaceutical Excipients Market Size Estimation Methodology-Bottom-up approach
To know about the assumptions considered for the study, Request for Free Sample Report
Top-down Approach-
Data Triangulation
After estimating the overall market size (pharmaceutical excipients market size) from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Pharmaceutical excipients are inactive substances added to medications alongside the active pharmaceutical ingredient (API). They serve various purposes, such as improving the drug's stability, bioavailability, delivery, and overall effectiveness. These components, including preservatives, binders, fillers, disintegrants, lubricants, and flavoring agents, contribute to the final drug product's quality and efficacy.
Key Stakeholders
-
Manufacturers, importers & exporters, traders, distributors, and suppliers of pharmaceutical excipients
-
Pharmaceutical and biopharmaceutical companies
-
Distributors and suppliers of pharmaceutical excipients
-
Contract manufacturing organizations (CMOs)
-
Suppliers and distributors of pharmaceutical products
-
Research and development (R&D) companies
-
Pharmaceutical/medical associations
-
Regulatory bodies & government agencies
-
Research institutes and government organizations
-
Venture capitalists and investors
-
Business research and consulting service providers
-
Market research and consulting firms
The main objectives of this study are as follows:
-
To define, describe, and forecast the pharmaceutical excipients market based on product, functionality, formulation, functionality applicatons and region.
-
To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
-
To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall antibody drug conjugate market.
-
To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders.
-
To forecast the size of the market segments with respect to six regions, namely: North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), the Middle East and Africa
-
To profile the key players and analyze their market shares and core competencies2
-
To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, expansions, and strategic alliances
-
To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Country-wise Information:
-
Analysis for additional countries (up to five)
Company Information:
-
Detailed analysis and profiling of additional market players (up to five)
User
Jul, 2019
Polyethylene oxide (PEO) is more commonly known as Polyethylene glycol (PEG) or poly(oxyethylene). The market for PEG has been provided under Section 7.2.3.1.1 of the Pharmaceutical Excipients Market report..
User
Jul, 2019
This report does not list Polyethylene Oxide..
Russell
Mar, 2022
Which region claims the largest share of Global Pharmaceutical Excipients Market?.
Bobby
Mar, 2022
How the leading companies are expecting to retain their position on the Global Pharmaceutical Excipients Market?.